Mouse Anti-Human S-100 alpha/beta chain Monoclonal Antibody, Unconjugated, Clone 8B10 from Santa Cruz Biotechnology, Inc.

Psoralen from Sigma-Aldrich

CleanBox DNA Workstation from Bio-Rad

Mouse Anti-Human VRK2 Monoclonal Antibody, Unconjugated, Clone 3B10 from Abnova Corporation

Mouse Anti-Human PPIL2 Monoclonal Antibody, Unconjugated, Clone 2E11 from Abnova Corporation

Psoralen from Sigma-Aldrich CleanBox DNA Workstation from Bio-Rad Mouse Anti-Human VRK2 Monoclonal Antibody, Unconjugated, Clone 3B10 from Abnova Corporation Mouse Anti-Human PPIL2 Monoclonal Antibody, Unconjugated, Clone 2E11 from Abnova Corporation

(Date:11/5/2009)...ty have developed synthetic molecules capable of e...-infected cells, as well as to prostate cancer cel...al of the American Chemical Society , could lead t... , The molecules called "antibody-recruiting m...iting molecule targeting prostate cancer" (ARM-P) ...

(Date:11/4/2009)...g Beach and Riverside are responsible for a signif...and the true impact of air pollution and ship emis...d, according to researchers at the University of S...pears in an online edition of the American Journa...f all childhood asthma cases in Long Beach and six...

(Date:11/4/2009)...eived more than $10 million in research grants fro...mulus program, bringing thetotal amount of stimulu...n. Thirty-three projects achieved stimulus fundin... , "The university has thoughtfully undertaken a... excellence to federal agency priorities. Through...

Breaking Biology News(10 mins):New synthetic molecules trigger immune response to HIV and prostate cancer 2 USC study finds big air pollution impacts on local communities 2 OU achieves $10 million in stimulus grants for 33 projects on the Norman campus 2 OU achieves $10 million in stimulus grants for 33 projects on the Norman campus 3 Zimmer Holdings to Present at Upcoming Investor Conferences 55934 1 DIA Conference to Explore The Science and Scope of Personalized Medicine 55930 1 DIA Conference to Explore The Science and Scope of Personalized Medicine 55930 2 U S Labor Department announces dates for 4th annual Drug Free Work Week 55926 1 U S Labor Department announces dates for 4th annual Drug Free Work Week 55926 2

[1] New synthetic molecules trigger immune response to HIV and prostate cancer [0] USC study finds big air pollution impacts on local communities [0] OU achieves $10 million in stimulus grants for 33 projects on the Norman campus

...nced Identification Systems/Commerc... 28 /PRNewswire-FirstCall/-- Atmel (Nasdaq:,ATML),...ns, announced today,that Kerry Maletsky, Business ...nt "Secure Biometric Co-processor: Solving the Net...on Systems/Commercial Biometrics,Conference in Was...

...MEA spurs IdentiPHI,s company ...tiPHI, Inc., an innovative,leader in enterprise se...sion with the opening of an office in Paris to add...identity and authentication (access,management) pr...ope will enable us to more closely serve our,growi...

...cans are an increasingly used X-ray-based tool for...r organ or tissue. The value of CT scanning to dia...undisputed. But are these scans being used too fre... health consequences of having too many CT scans o... 2007 article in The New England Journal of Medici...

Other Biology News:Atmel's Biometric Co-processor Solution Featured at AIS/CBX 2 IdentiPHI Opens Paris Office to Boost European Sales and Support 2 Columbia researchers: Growth of CT scan use may lead to significant public health problem 2 Columbia researchers: Growth of CT scan use may lead to significant public health problem 3

Atmel's Biometric Co-processor Solution Featured at AIS/CBX IdentiPHI Opens Paris Office to Boost European Sales and Support Columbia researchers: Growth of CT scan use may lead to significant public health problem

(Date:11/5/2009)...Nov. 5 Transgenomic, Inc...cial results for the quarter ended September 30, 2... in the tables that follow. ,, Third Quarter 2...,000 or $0.01 per share for the third quarter of 2... per share for the third quarter of 2008. ,, N...

(Date:11/5/2009)...f., Nov. 5 WaferGen Bios... developer of state-of-the-art genetic analysis sy...D. has joined the company,s Scientific Advisory Bo... commercializing novel molecular diagnostics for c... development of computational biology systems for ...

(Date:11/5/2009)... Brooke Sanders brings a new look to Pro Rep...ovember 5, 2009 -- Professional Reprographics, Ora...ompany is pleased to present Brooke Sanders to the...cs/PR specialist. The addition of Brooke to the co...ithin Professional Reprographics., , ,Brooke bring...

(Date:11/4/2009)...KVILLE, Md., Nov. 4 Zyngenia, Inc.... on next-generation antibody drug development, tod...ries A funding from New Enterprise Associates (NEA...s. The capital will be used to create novel, multi... or more biological targets with a single agent. T...

Breaking Biology Technology:Transgenomic, Inc. Reports Third Quarter 2009 Results 2 Transgenomic, Inc. Reports Third Quarter 2009 Results 3 Transgenomic, Inc. Reports Third Quarter 2009 Results 4 Transgenomic, Inc. Reports Third Quarter 2009 Results 5 Transgenomic, Inc. Reports Third Quarter 2009 Results 6 Transgenomic, Inc. Reports Third Quarter 2009 Results 7 WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 2 WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 3 WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 4 Zyngenia, Inc. Raises $10 Million in Series A Funding 2 Zyngenia, Inc. Raises $10 Million in Series A Funding 3 Zyngenia, Inc. Raises $10 Million in Series A Funding 4

[0] Transgenomic, Inc. Reports Third Quarter 2009 Results [0] WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board [0] Professional Reprographics Hires Recent Cal Poly Grad to Join their Team [0] Zyngenia, Inc. Raises $10 Million in Series A Funding

Products	Mouse Anti-Human S-100 alpha/beta chain Monoclonal Antibody, Unconjugated, Clone 8B10 from Santa Cruz Biotechnology, Inc.
Company	Santa Cruz Biotechnology, Inc.
Item	Mouse Anti-Human S-100 alpha/beta chain Monoclonal Antibody, Unconjugated, Clone 8B10
Price	$238.00
Description	S-100 alpha/beta chain (8B10)
Info	Santa Cruz Biotechnology, Inc. 2145 Delaware Avenue Santa Cruz, California 95060 U.S.A. Customer Service: 1-800-457-3801 Fax Number: 831-457-3801 Web Site: http://www.scbt.com/